ArticleTechnology in cancer research & treatment

Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer.

Xue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.